tetano
Editor, Senior Moderator
Heart Lung Circ
. 2021 Mar 6;S1443-9506(21)00075-5.
doi: 10.1016/j.hlc.2021.02.010. Online ahead of print.
Atrial Fibrillation as a Predictor of Mortality in High Risk COVID-19 Patients: A Multicentre Study of 171 Patients
Randy J Ip[SUP] 1 [/SUP], Abbas Ali[SUP] 2 [/SUP], Zulfiqar Qutrio Baloch[SUP] 3 [/SUP], Abdullah Al-Abcha[SUP] 3 [/SUP], Chris Jacob[SUP] 4 [/SUP], Jelena Arnautovic[SUP] 5 [/SUP], Manel Boumegouas[SUP] 3 [/SUP], Steven Do[SUP] 3 [/SUP], Krishna Meka[SUP] 5 [/SUP], Matthew Wilcox[SUP] 3 [/SUP], John Ip[SUP] 3 [/SUP]
Affiliations
Abstract
Purpose: Certain patient demographics and biomarkers have been suggested to predict survival in patients infected with COVID-19. However, predictors of outcome in patients who are critically ill are unclear.
Materials and methods: We performed a multicentre analysis of 171 consecutive patients with confirmed COVID-19 who were admitted to the intensive care unit (ICU) between 1 March 2020 and 30 April 2020 and were followed until 23 May 2020. Demographic data, past medical history, laboratory values, echocardiographic and telemetry data were analysed. Patient status was classified as either alive or deceased at hospital discharge or the end of follow-up period.
Results: Mean patient age was 66?13 and 57% were male. Mortality rate of this ICU cohort at the end of follow-up was 46.2%. A multivariable logistic regression analysis identified the presence or history of atrial fibrillation (Odds Ratio 4.8, p=0.004) as a significant cardiovascular attribute that contributed to increased mortality.
Conclusion: Mortality of critically ill COVID-19 patients is high. This study suggests a relationship between atrial fibrillation and increased mortality from COVID-19. Early aggressive treatment patients with high risk characteristics, such as atrial fibrillation could improve clinical outcome.
Keywords: Atrial fibrillation; COVID-19; Coronavirus; Mortality.
. 2021 Mar 6;S1443-9506(21)00075-5.
doi: 10.1016/j.hlc.2021.02.010. Online ahead of print.
Atrial Fibrillation as a Predictor of Mortality in High Risk COVID-19 Patients: A Multicentre Study of 171 Patients
Randy J Ip[SUP] 1 [/SUP], Abbas Ali[SUP] 2 [/SUP], Zulfiqar Qutrio Baloch[SUP] 3 [/SUP], Abdullah Al-Abcha[SUP] 3 [/SUP], Chris Jacob[SUP] 4 [/SUP], Jelena Arnautovic[SUP] 5 [/SUP], Manel Boumegouas[SUP] 3 [/SUP], Steven Do[SUP] 3 [/SUP], Krishna Meka[SUP] 5 [/SUP], Matthew Wilcox[SUP] 3 [/SUP], John Ip[SUP] 3 [/SUP]
Affiliations
- PMID: 33781697
- DOI: 10.1016/j.hlc.2021.02.010
Abstract
Purpose: Certain patient demographics and biomarkers have been suggested to predict survival in patients infected with COVID-19. However, predictors of outcome in patients who are critically ill are unclear.
Materials and methods: We performed a multicentre analysis of 171 consecutive patients with confirmed COVID-19 who were admitted to the intensive care unit (ICU) between 1 March 2020 and 30 April 2020 and were followed until 23 May 2020. Demographic data, past medical history, laboratory values, echocardiographic and telemetry data were analysed. Patient status was classified as either alive or deceased at hospital discharge or the end of follow-up period.
Results: Mean patient age was 66?13 and 57% were male. Mortality rate of this ICU cohort at the end of follow-up was 46.2%. A multivariable logistic regression analysis identified the presence or history of atrial fibrillation (Odds Ratio 4.8, p=0.004) as a significant cardiovascular attribute that contributed to increased mortality.
Conclusion: Mortality of critically ill COVID-19 patients is high. This study suggests a relationship between atrial fibrillation and increased mortality from COVID-19. Early aggressive treatment patients with high risk characteristics, such as atrial fibrillation could improve clinical outcome.
Keywords: Atrial fibrillation; COVID-19; Coronavirus; Mortality.